Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Ransom

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Plos One|August 29, 2025
Assessing fecal pollution source in a Northern Michigan Lake using qPCR and a community-based monitoring frameworkKelsey L Froelich, Ronald L Reimink, Ceilidh P Welch, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2002
Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiationYoh-Ichi Seki, Katsuhiko Hayashi, Akira Matsumoto, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|February 2, 2023
Enhanced Thrombin Formation in Patients With Ventricular Assist Devices Experiencing Bleeding: Insights From the Multicenter PREVENT StudyWalter Jeske, John Ransom, Jason N Katz, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 3, 2023
Association of Angiopoetin-2 and TNF-α With Bleeding During Left Ventricular Assist Device Support: Analysis From the PREVENT BiorepositoryGene Kim, Gabriel Sayer, John Ransom, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 29, 2018
Pump Position Impacts HeartMate II Left Ventricular Assist Device ThrombosisAhmet Kilic, John Ransom, Simon Maltais, et al.
Circulation. Heart Failure|September 16, 2021
Impact of Race on Clinical Outcomes After Implantation With a Fully Magnetically Levitated Left Ventricular Assist Device: An Analysis From the MOMENTUM 3 TrialFarooq H Sheikh, Ashwin K Ravichandran, Daniel J Goldstein, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 21, 2016
PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management: The PREVENT multi-center studySimon Maltais, Ahmet Kilic, Sriram Nathan, et al.
JAMA Cardiology|January 16, 2020
Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical TrialDaniel J Goldstein, Yoshifumi Naka, Douglas Horstmanshof, et al.
JAMA|November 11, 2023
Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical TrialMandeep R Mehra, Ivan Netuka, Nir Uriel, et al.
The New England Journal of Medicine|March 19, 2019
A Fully Magnetically Levitated Left Ventricular Assist Device - Final ReportMandeep R Mehra, Nir Uriel, Yoshifumi Naka, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Plos One|August 29, 2025
Assessing fecal pollution source in a Northern Michigan Lake using qPCR and a community-based monitoring frameworkKelsey L Froelich, Ronald L Reimink, Ceilidh P Welch, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2002
Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiationYoh-Ichi Seki, Katsuhiko Hayashi, Akira Matsumoto, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|February 2, 2023
Enhanced Thrombin Formation in Patients With Ventricular Assist Devices Experiencing Bleeding: Insights From the Multicenter PREVENT StudyWalter Jeske, John Ransom, Jason N Katz, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 3, 2023
Association of Angiopoetin-2 and TNF-α With Bleeding During Left Ventricular Assist Device Support: Analysis From the PREVENT BiorepositoryGene Kim, Gabriel Sayer, John Ransom, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 29, 2018
Pump Position Impacts HeartMate II Left Ventricular Assist Device ThrombosisAhmet Kilic, John Ransom, Simon Maltais, et al.
Circulation. Heart Failure|September 16, 2021
Impact of Race on Clinical Outcomes After Implantation With a Fully Magnetically Levitated Left Ventricular Assist Device: An Analysis From the MOMENTUM 3 TrialFarooq H Sheikh, Ashwin K Ravichandran, Daniel J Goldstein, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 21, 2016
PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management: The PREVENT multi-center studySimon Maltais, Ahmet Kilic, Sriram Nathan, et al.
JAMA Cardiology|January 16, 2020
Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical TrialDaniel J Goldstein, Yoshifumi Naka, Douglas Horstmanshof, et al.
JAMA|November 11, 2023
Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical TrialMandeep R Mehra, Ivan Netuka, Nir Uriel, et al.
The New England Journal of Medicine|March 19, 2019
A Fully Magnetically Levitated Left Ventricular Assist Device - Final ReportMandeep R Mehra, Nir Uriel, Yoshifumi Naka, et al.
Pageof 1